发布时间：2008.9

摘要

Description
This report is an essential source for in-depth information and data relating to the Egypt cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the cardiovascular devices in Egypt

 
Scope
The report provides cardiovascular devices market information broken down into detailed categories and segments in Egypt.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.
 
Reasons to buy
Gain a strong understanding of the cardiovascular devices market in Egypt.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
 
目录及图表

Table of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Cardiovascular Devices
3 Healthcare Sector Review
3.1 Healthcare Expenditure
3.2 Healthcare Infrastructure
3.2.1 Healthcare Personnel Data
3.2.2 Healthcare Facilities Data
3.3 Healthcare Policy
4 Cardiovascular Devices in Egypt
4.1 Cardiovascular Devices Overall Revenues (2000-2012)
4.2 Cardiovascular Devices Overall Volume (2000-2012)
4.3 Cardiovascular Devices Overall Company Share (2005-2006)
5 Cardiac Rhythm Management in Egypt
5.1 Cardiac Rhythm Management Overall Revenue (2000-2012)
5.1.1 Defibrillator Overall Revenues (2000-2012)
5.1.2 Pacemaker Overall Revenues (2000-2012)
5.1.3 Cardiovascular Leads and Lead System Overall Revenues (2000-2012)
5.2 Cardiac Rhythm Management Overall Volumes (2000-2012)
5.2.1 Cardiovascular leads and lead System Overall Volume (2000-2012)
5.2.2 Pacemaker Overall Volume (2000-2012)
5.2.3 Defibrillator Overall Volume (2000-2012)
5.3 Cardiac Rhythm Management Average Price (2000-2012)
5.3.1 Pacemaker Average Price (2000-2012)
5.3.2 Defibrillator Average Price (2000-2012)
5.3.3 Cardiovascular Leads and Lead System Average Price (2000-2012)
5.4 Cardiac Rhythm Management Distribution Share (2005-2006)
5.5 Cardiac Rhythm Management Company Share (2005-2006)
6 Interventional Cardiology in Egypt
6.1 Interventional Cardiology Overall Revenues (2000-2012)
6.1.1 Coronary Stent Overall Revenues (2000-2012)
6.1.2 PTCA Balloon Overall Revenues (2000-2012)
6.1.3 Cardiac Catheter Overall Revenues (2000-2012)
6.2 Interventional Cardiology Overall Volumes (2000-2012)
6.2.1 Cardiac Catheter Overall Volumes (2000-2012)
6.2.2 Coronary Stents Overall Volume (2000-2012)
6.2.3 PTCA Balloon Overall Volumes (2000-2012)
6.3 Interventional Cardiology Average Price (2000-2012)
6.3.1 Coronary stents Average Price (2000-2012)
6.3.2 Cardiac Catheter Average price (2000-2012)
6.3.3 PTCA Balloon Average Price (2000-2012)
6.4 Interventional Cardiology Distribution Share (2005-2006)
6.5 Interventional Cardiology Company Share (2005-2006)
7 Cardiovascular Surgery in Egypt
7.1 Cardiovascular Surgery Overall Revenues (2000-2012)
7.1.1 Perfusion System Overall Revenues (2000-2012)
7.1.2 Cardiac Ablation Device Overall Revenues (2000-2012)
7.1.3 Beating Heart Surgery System Overall Revenues (2000-2012
7.2 Cardiovascular Surgery Overall Volume (2000-2012)
7.2.1 Beating Heart Surgery System Overall Volume (2000-2012)
7.2.2 Cardiac Ablation Device Overall Volume (2000-2012)
7.2.3 Perfusion System Overall Volume (2000-2012)
7.3 Cardiovascular Surgery Average Price (2000-2012)
7.3.1 Beating Heart Surgery System Average Price (2000-2012)
7.3.2 Cardiac Ablation Device Average Price (2000-2012)
7.3.3 Perfusion System Average Price (2000-2012)
7.4 Cardiovascular Surgery Distribution Share (2000-2012)
7.5 Cardiovascular Surgery Company Share (2000-2012)
8 Peripheral Vascular Devices in Egypt
8.1 Peripheral Vascular Devices Overall Revenue (2000-2012)
8.1.1 Peripheral Vascular Stent Overall Revenues (2000-2012)
8.1.2 PTA Balloon Overall Revenues (2000-2012)
8.1.3 Arotic Stent Graft Market Overall Revenues (2000-2012)
8.1.4 Inferior Vena Cava Filter Overall Revenues (2000-2012)
8.2 Peripheral Vascular Devices Overall Volume (2000-2012)
8.2.1 Peripheral Vascular Stent Overall Volume (2000-2012)
8.2.2 PTA Balloon Overall Volume (2000-2012)
8.2.3 Inferior Vena Cava Filter Overall Volume (2000-2012)
8.2.4 Arotic Stent Graft Market Overall Volume (2000-2012)
8.3 Peripheral Vascular Devices Average Price (2000-2012)
8.3.1 Peripheral Vascular Stents Average Price (2000-2012)
8.3.2 Inferior Vena Cava Filter Average Price (2000-2012)
8.3.3 PTA Balloon Average Price (2000-2012)
8.3.4 Arotic Stent Graft Market Average Price (2000-2012)
8.4 Peripheral Vascular Devices Distribution Share (2005-2006)
8.5 Peripheral Vascular Devices Company Share (2005-2006)
9 Cardiovascular Prosthetic Devices in Egypt
9.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2012)
9.1.1 Prosthetic Heart Valve Overall Revenues (2000-2012)
9.1.2 Cardiac Assist Device Overall Revenues (2000-2012)
9.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2012)
9.2.1 Prosthetic Heart Valve Overall Volume (2000-2012)
9.2.2 Cardiac Assist Device Overall Volume (2000-2012)
9.3 Cardiovascular Prosthetic Devices Average Price (2000-2012)
9.3.1 Prosthetic Heart Valve Average Price (2000-2012)
9.3.2 Cardiac Assist Devices Average Price (2000-2012)
9.4 Cardiovascular Prosthetic Devices Distribution Share (2005-2006)
9.5 Cardiovascular Prosthetic Devices Company Share (2005-2006)
10 Cardiovascular Monitoring and Diagnostic Devices in Egypt
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2012)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2012)
10.2.1 ECG Monitoring Equipment Overall Volume (2000-2012)
10.2.2 Holter Monitoring System Overall Volume (2000-2012)
10.2.3 Event Monitoring System Overall Volume (2000-2012)
10.2.4 ECG Stress Testing System Overall Volume (2000-2012)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2005-2006)
10.3.1 ECG Monitoring Equipment Average Price (2000-2012)
10.3.2 ECG Stress Testing System Average Price (2000-2012)
10.3.3 Holter Monitoring System Average Price (2000-2012)
10.3.4 Event Monitoring System Average Price (2000-2012)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2005-2006)
10.5 Cardiovascular Monitoring and Diagnostic Devices Company Share (2005-2006)
11 Overview of Key Companies
11.1 Medtronic, Inc.
11.2 Boston Scientific Corporation
11.3 Cordis Corporation
11.4 St. Jude Medical Inc.
11.5 Terumo Corporation
11.6 Abbott Laboratories
12 News
13 Deals
14 Regulation System
14.1 Medical Equipment Approval
14.2 Central Drugs Authority
14.3 Medical Device Regulatory Authority
14.4 Classification of medical devices
14.4.1 Registration Period
15 Pricing and Reimbursement
16 Distribution Structure
17 APPENDIX
17.1 Methodology
17.2 Currency Conversion
17.3 Contact Us
17.4 Disclaime
Note: Some content types may not be available in this report